Breakfast for the Bold: Building the Digital Backbone of Clinical Research

Breakfast for the Bold: Building the Digital Backbone of Clinical Research

Join us for an engaging breakfast conversation shaping the next generation of clinical trials, featuring a panel discussion with Kimberly Tabelman (ESPERO), Matthew Morano (Sunshine MD) and Karen Travers (Halloran Consulting Group).

From digital protocol transformation to intelligent site selection, we’ll explore what it takes to move from vision to real-world adoption. Come hungry—for both ideas and breakfast—and leave inspired to lead your organization toward a more data-driven, adaptive future of clinical research.

Register now to secure your spot!

About ESPERO

ESPERO is transforming clinical research through digital protocol intelligence—turning unstructured study documents into standardized, analyzable data that powers smarter design, faster startup, and more informed site selection. By connecting ICH-M11 and USDM standards with real-world insights, ESPERO helps sponsors and partners move confidently toward the future of data-driven research.

About Sunshine MD

Sunshine MD is redefining clinical operations through technology-enabled site partnerships and patient-centered research delivery. With a focus on access, quality, and digital enablement, Sunshine MD empowers investigators and sponsors to bring trials closer to communities—accelerating enrollment and improving outcomes across diverse populations.

About Halloran Consulting Group

Halloran Consulting Group, a ProductLife Group company, is a trusted life science consulting firm helping pharmaceutical, biotech, and medical device organizations navigate regulatory complexity, accelerate development, and achieve operational excellence. With offices in Boston and San Diego, Halloran’s expert team delivers customized solutions that drive innovation and support the patients their clients serve.